SEC Form 4
Hemab Therapeutics Holdings, Inc. (COAG) insider trading
In the 12 months to Nov 19, 2026, 2 COAG insiders reported open-market purchases of $55.5M across 8 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $55.5M
- 8 filings
Who traded COAG, and when
- Purchase
COAG daily close from May 1, 2026 to Nov 18, 2026, between $24.98 and $54.94, last $39.15. 0 sale and 8 purchase filings by 2 insiders, marked at their filing dates. Rajeev M. Shah, Director → 10% owner: bought $53.1M across 5 filings, first filed May 6, 2026, last Jun 17, 2026. Peter Kolchinsky, Director → 10% owner: bought $2.3M across 3 filings, first filed May 6, 2026, last Jun 17, 2026.
Largest mark · tap a row for others
Rajeev M. Shah · Director
Filing 1 of 2 within a week · $51,320,195 total
Purchase $50,640,150
2,776,754 shares at $18.24 avg
Filed May 6, 2026 · traded May 4
Close on filing date $25.01
Rajeev M. Shah · Director → 10% owner
Director → 10% owner
$53.1M boughtPeter Kolchinsky · Director → 10% owner
Director → 10% owner
$2.3M boughtOpen-market trades
8 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Rajeev M. Shah | Director → 10% owner | — | $53.1M | 5 | — | |
| Peter Kolchinsky | Director → 10% owner | — | $2.3M | 3 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Peter Kolchinsky 10% owner | Purchase | 6,146 | $24.89 | $153.0K | 6,383,114 | |
traded | Rajeev M. Shah 10% owner | Purchase | 61,523 | $24.98 | $1.5M | 6,444,637 | |
traded | Rajeev M. Shah 10% owner | Purchase | 4,798 | $24.96 | $119.8K | 6,376,968 | |
traded | Rajeev M. Shah 10% owner | Purchase | 6,387 | $24.90 | $159.0K | 6,372,170 | |
traded | Peter Kolchinsky 10% owner | Purchase | 24,055 | $24.47 | $588.5K | 6,340,063 | |
traded | Rajeev M. Shah 10% owner | Purchase | 27,203 | $25.00 | $680.0K | 6,365,783 | |
traded | Peter Kolchinsky Director | Purchase | 63,675 | $24.86 | $1.6M | 6,314,525 | |
traded | Rajeev M. Shah Director | Purchase | 2,776,754 | $18.24 | $50.6M | 6,261,118 |
GET /stocks/filings/vX/form-4?tickers=COAG&filing_date.gte=2025-11-19&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"COAG"
],
"issuer_cik": "0002114044",
"owner_cik": "0001346824",
"accession_number": "0001231919-26-000665",
"form_type": "4",
"filing_date": "2026-06-17",
"period_of_report": "2026-06-15",
"issuer_name": "Hemab Therapeutics Holdings, Inc.",
"issuer_trading_symbol": "COAG",
"owner_name": "RA CAPITAL MANAGEMENT, L.P.",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-06-16",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 61523,
"transaction_price_per_share": 24.98,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 6444637,
"transaction_value": 1536844.54,
"direct_or_indirect": "I",
"nature_of_ownership": "See footnotes",
"footnotes": [
{
"id": "F4",
"description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.65 to $25.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."
},
{
"id": "F2",
"description": "RA Capital Management, L.P. (the \"Adviser\") is the investment manager for RA Capital Healthcare Fund, L.P. (the \"Fund\"), RA Capital Nexus II Fund, L.P. (the \"Nexus Fund II\") and RA Capital Nexus IV Fund, L.P. (the \"Nexus Fund IV\"). The general partner of the Adviser is RA Capital Management GP, LLC (the \"Adviser GP\"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein."
},
{
"id": "F3",
"description": "Held directly by the Fund."
}
]
},
{
"tickers": [
"COAG"
],
"issuer_cik": "0002114044",
"owner_cik": "0001384859",
"accession_number": "0001231919-26-000665",
"form_type": "4",
"filing_date": "2026-06-17",
"period_of_report": "2026-06-15",
"issuer_name": "Hemab Therapeutics Holdings, Inc.",
"issuer_trading_symbol": "COAG",
"owner_name": "Kolchinsky Peter",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-06-15",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 6146,
"transaction_price_per_share": 24.89,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 6383114,
"transaction_value": 152973.94,
"direct_or_indirect": "I",
"nature_of_ownership": "See footnotes",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.55 to $25.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."
},
{
"id": "F2",
"description": "RA Capital Management, L.P. (the \"Adviser\") is the investment manager for RA Capital Healthcare Fund, L.P. (the \"Fund\"), RA Capital Nexus II Fund, L.P. (the \"Nexus Fund II\") and RA Capital Nexus IV Fund, L.P. (the \"Nexus Fund IV\"). The general partner of the Adviser is RA Capital Management GP, LLC (the \"Adviser GP\"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein."
},
{
"id": "F3",
"description": "Held directly by the Fund."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 6 records
- Other6 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Role
- The title on each filing. Someone whose title changed shows more than one.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
How current is COAG’s insider data?
These are COAG Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track COAG insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for COAG every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.